The French CONSTANCES population-based cohort: design, inclusion and follow-up

European Journal of Epidemiology

Volumn 30, Issue 12, 2015, Pages 1317-1328

  Zins, Marie ^a,b   Goldberg, Marcel ^a  

^a UMS 011   (France)

^b LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

Author keywords

Aging; Chronic diseases; Population based cohort; Socioeconomic factors

Indexed keywords

ACTIVITY OF DAILY LIVING ASSESSMENT; ADULT; AGED; AGING; ARTICLE; CHRONIC DISEASE; COHORT ANALYSIS; DEMOGRAPHY; FEMALE; FOLLOW UP; FRANCE; GEOGRAPHIC DISTRIBUTION; HEALTH CARE UTILIZATION; HEALTH INSURANCE; HUMAN; INSTRUMENTAL ACTIVITIES OF DAILY LIVING SCALE; LIFESTYLE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; MIDDLE AGED; OCCUPATION; PERIODICITY; POPULATION RESEARCH; PUBLIC HEALTH CAMPAIGN; QUALITY CONTROL; QUESTIONNAIRE; SELF REPORT; SOCIAL ASPECT; SOCIAL STATUS; SOCIOECONOMICS; STUDY DESIGN; VALIDATION STUDY; WORK ENVIRONMENT; ADOLESCENT; EPIDEMIOLOGY; FACTUAL DATABASE; HEALTH SURVEY; INFORMATION PROCESSING; MEDICAL INFORMATICS; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGING; CHRONIC DISEASE; COHORT STUDIES; DATA COLLECTION; DATABASES, FACTUAL; EPIDEMIOLOGIC METHODS; FEMALE; FOLLOW-UP STUDIES; FRANCE; HUMANS; MIDDLE AGED; POPULATION SURVEILLANCE; PUBLIC HEALTH INFORMATICS; SOCIOECONOMIC FACTORS; YOUNG ADULT;

EID: 84952638629     PISSN: 03932990     EISSN: 15737284     Source Type: Journal    
DOI: 10.1007/s10654-015-0096-4     Document Type: Article

References (63)

1. Burton PR, et al. Size matters: Just how big is BIG? Quantifying realistic sample size requirements for human genome epidemiology. Int J Epidemiol. 2009;38:263–73.
2. Collins FS. The case for a US prospective cohort study of genes and environment. Nature. 2004;429:475–7.
3. Newton-Cheh C, et al. Eight blood pressure loci identified by genomewide association study of 34,433 people of European ancestry. Nat Genet. 2009;41:666–76.
4. Oppenheimer GM. Becoming the Framingham study. Am J Public Health. 2005;95:602–10.
5. Egan KM, Stampfe MJ, Hunter D, Hankinson S, Rosner BA, Holmes M, Willett WC, Colditz GA. Active and passive smoking in breast cancer: prospective results from the Nurses’ Health Study. Epidemiology. 2002;13:138–45.
6. Darling GM, Johns JA, McCloud PI, Davis SR. Estrogen and progestin compared with simvastatin for hypercholesterolemia in postmenopausal women. N Engl J Med. 1998;338:64.
7. Collins R, UK Biobank Steering Committee. UK Biobank: protocol for a large-scale prospective epidemiological resource. Manchester: UK Biobank Coordinating Centre; 2007.
8. Chen Z, Lee L, Chen J, Collins R, Wu F, Guo Y, Linksted P, Peto R. Cohort profile: the Kadoorie study of chronic disease in China (KSCDC). Int J Epidemiol. 2005;34:1243–9.
9. Naess O, et al. Cohort profile: cohort of Norway (CONOR). Int J Epidemiol. 2008;37(3):481–5.
10. Riboli E, Hunt KJ, Slimani N, Ferrari P, Norat T, Fahey M, Charrondière UR, Hémon B, Casagrande C, Vignat J, Overvad K, Tjønneland A, Clavel-Chapelon F, Thiébaut A, Wahrendorf J, Boeing H, Trichopoulos D, Trichopoulou A, Vineis P, Palli D, Bueno-De-Mesquita HB, Peeters PH, Lund E, Engeset D, González CA, Barricarte A, Berglund G, Hallmans G, Day NE, Key TJ, Kaaks R, Saracci R. European prospective investigation into cancer and nutrition (EPIC): study populations and data collection. Public Health Nutr. 2002;5:1113–24.
11. Stolk RP, Rosmalen JG, Postma DS, de Boer RA, Navis G, Slaets JP, Ormel J, Wolffenbuttel BH. Universal risk factors for multifactorial diseases: lifeLines: a three-generation population-based study. Eur J Epidemiol. 2008;23(1):67–74.
12. German National Cohort (GNC) Consortium. The German National Cohort: aims, study design and organization. Eur J Epidemiol. 2014;29:371–82.
13. lifegene.ki.se. Accessed 31 July 2015.
14. http://cartagene.qc.ca/en. Accessed 31 July 2015.
15. GAZEL. http://www.gazel.inserm.fr.
16. Goldberg M, Leclerc A, Bonenfant S, Chastang JF, Schmaus A, Kaniewski N, Zins M. Cohort profile: the GAZEL cohort study. Int J Epidemiol. 2007;36:32–9.
17. Zins M, Leclerc A, Goldberg M. The French GAZEL cohort study: 20 years of epidemiologic research. Adv Life Course Res. 2009;14:135–46.
18. Siemiatycki J, et al. Listing occupational carcinogens. Environ Health Perspect. 2004;112(15):1447–59.
19. Kilbom S, Armstrong T, Buckle P, Fine L, Hagberg M, Haring-Sweeney M, Martin B, Punnett L, Silverstein B, Sjøgaard G, Theorell T, Viikari-Juntura E. Musculoskeletal disorders: work-related risk factors and prevention. Int J Occup Environ Health. 1996;2(3):239–46.
20. Roche N, Dalmay F, Perez T, Kuntz C, Vergnenègre A, Neukirch F, Giordanella JP, Huchon G. Impact of chronic airflow obstruction in a working population. Eur Respir J. 2008;31:1227–33.
21. Brayne C. The elephant in the room—healthy brains in later life, epidemiology and public health. Nat Rev Neurosci. 2007;8(3):233–9.
22. Kivimaki M, Nyberg ST, Batty GD, Fransson EI, Heikkilä K, Alfredsson L, Bjorner JB, Borritz M, Burr H, Casini A, Clays E, De Bacquer D, Dragano N, Ferrie JE, Geuskens GA, Goldberg M, Hamer M, Hooftman WE, Houtman IL, Joensuu M, Jokela M, Kittel F, Knutsson A, Koskenvuo M, Koskinen A, Kouvonen A, Kumari M, Madsen IEH, Marmot MG, Nielsen ML, Nordin M, Oksanen T, Pentti J, Rugulies R, Salo P, Siegrist J, Singh-Manoux A, Suominen SB, Väänänen A, Vahtera J, Virtanen M, Westerholm PJM, Westerlund H, Zins M, Steptoe A, Theorell T, for the IPD-Work Consortium. Job strain as a risk factor for future coronary heart disease: collaborative analysis of 2358 events in 197,473 men and women. Lancet. 2012;. doi:10.1016/S0140-6736(12)60994-5.
23. Niedhammer I, Goldberg M, Leclerc A, Bugel I, David S. Psychosocial factors at work and subsequent depressive symptoms in the GAZEL cohort. Scand J Work Environ Health. 1998;24:197–205.
24. Schuring M, Robroek SJ, Lingsma HF, Burdorf A. Educational differences in trajectories of self-rated health before, during, and after entering or leaving paid employment in the European workforce. Scand J Work Environ Health. 2015;. doi:10.5271/sjweh.3514.
25. Marmot M, et al. Closing the gap in a generation: health equity through action on the social determinants of health. Lancet. 2008;372:1661–9.
26. Dartigues JF, Alpérovitch A. Épidémiologie et vieillissement. In: Valleron AJ, editor. Épidémiologie: conditions de son développement, et rôle des mathématiques. Rapport sur la Science et la Technologie n° 23, Comité RST de l’Académie des sciences. Éditions EDP Sciences, 2006.
27. Christensen K, Doblhammer G, Rau R, Vaupel JW. Ageing populations: the challenges ahead. Lancet. 2009;374:1196–208.
28. Gill TM, Gahbauer EA, Han L, Allore HG. Trajectories of disability in the last year of life. N Engl J Med. 2010;362:1173–80.
29. Jagger C, Gillies C, Moscone F, Cambois E, Van Oyen H, Nusselder W, Robine JM, EHLEIS team. Inequalities in healthy life years in the 25 countries of the European Union in 2005: a cross-national meta-regression analysis. Lancet. 2008;372:2124–31.
30. CepiDC. http://www.cepidc.vesinet.inserm.fr/.
31. Remontet L, Buemi A, Velten M, Jougla E, Estève J. Évolution de l’incidence et de la mortalité par cancer en France de 1978 à 2000. InVS: Saint Maurice; 2002.
32. ARME. Incidence et prévalence de différentes maladies. Bordeaux: ARME Pharmacovigilance; 2007.
33. CNAV. http://www.cnav.fr/.
34. Le Lenormand F. Système d’information de l’assurance maladie, le SNIIRAM et les échantillons de bénéficiaires. Courrier des statistiques. 2005;33:113–4.
35. http://www.constances.fr/medias/base-documentaire/2015/1431338816-inclusion-data.pdf. Accessed 31 July 2015.
36. http://www.constances.fr/medias/base-documentaire/2015/1431338760-follow-up-data.pdf. Accessed 31 July 2015.
37. Févotte J, Dananché B, Delabre L, Ducamp S, Garras L, Houot M, Luce D, Orlowski E, Pilorget C, Lacourt A, Brochard P, Goldberg M, Imbernon E. MATGENE: a program to develop job-exposure matrices in the general population in France. Ann Occup Hyg. 2011;55:865–78.
38. Finch CE. The neurobiology of middle-age has arrived. Neurobiol Aging. 2009;30:515–20.
39. Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist. 1969;9:179–86.
40. Folstein M, Anthony JC, Parhad I, Duffy B, Gruenberg EM. The meaning of cognitive impairment in the elderly. J Am Geriatr Soc. 1985;33:228–35.
41. Boll TJ, Reitan RM. Effect of age on performance of the Trail Making Test. Percept Mot Skills. 1973;36:691–4.
42. Miner T, Ferraro FR. The role of speed of processing, inhibitory mechanisms, and presentation order in trail-making test performance. Brain Cogn. 1998;38:246–53.
43. Wechsler D. Manual for the Wechsler Adulte Intelligence Scale—revised. New-York: Psychological Corporation; 1981.
44. Mitrushina MN, Boone KB, D’Elia LF. Handbook of normative data for neuropsychological assessment. New York: Oxford University Press; 1999.
45. Borkowski JG, Benton AL, Spreen O. Word fluency and brain damage. Neuropsychologica. 1967;5:135–40.
46. Cardebat D, Doyon B, Puel M, Goulet P, Joanette Y. Formal and semantic lexical evocation in normal subjects. Performance and dynamics of production as a function of sex, age and educational level. Acta Neurol Belg. 1990;90:207–17.
47. Grober E, Buschke H, Crystal H, Bang S, Dresner R. Screening for dementia by memory testing. Neurology. 1988;38:900–3.
48. Van der Linden M, Coyette F, Poitrenaud J, Kalafat M, Calicis F, Wyns C, Adam S et les membres du GREMEM. L’épreuve de rappel libre/rappel indicé à 16 items (RL/RI-16). L’évaluation des troubles de la mémoire. Van der Linden M et les membres du GREMEM, editors. Solal Éditeur, Marseille, 2004.
49. Shkuratova N, Morris ME, Huxham F. Effects of age on balance control during walking. Arch Phys Med Rehabil. 2004;85:582–8.
50. Horak FB, Shupert CL, Mirka A. Components of postural dyscontrol in the elderly: a review. Neurobiol Aging. 1989;10:727–38.
51. Giampaoli S, Ferrucci L, Cecchi F, LoNoce C, Poce A, Dima F, Santaquilani A, Vescio MF, Menotti A. Hand-grip strength predicts incident disability in non-disabled older men. Age Ageing. 1999;28:283–8.
52. Goldberg M, Luce D. Les effets de sélection dans les cohortes épidémiologiques. Nature, causes et conséquences. Rev Epidemiol Santé Publique. 2001;49:477–92.
53. Groves RM. Nonresponse rates and nonresponse bias in household surveys. Public Opin Q. 2006;70:646–75.
54. Criqui MH. Response bias and risk ratios in epidemiologic studies. Am J Epidemiol. 1979;109:394–9.
55. Austin MA, Criqui MH, Barrett-Connor E, Holdbrook MJ. The effect of response bias on the odds-ratio. Am J Epidemiol. 1981;1981(114):137–43.
56. Groves RM, Peytcheva E. The impact of nonresponse rates on nonresponse bias. Public Opin Q. 2008;72:167–89.
57. Goldberg M, Chastang JF, Zins M, Niedhammer I, Leclerc A. Health problems were the strongest predictors of attrition during follow up of the GAZEL cohort. J Clin Epidemiol. 2006;59:1213–21.
58. Goldberg M, Chastang JF, Leclerc A, Zins M, Bonenfant S, Bugel I, Kaniewski N, Schmaus A, Niedhammer I, Piciotti M, Chevalier A, Godard C, Imbernon E. Socioeconomic, demographic, occupational and health factors associated with participation in a long-term epidemiologic survey. A prospective study of the French GAZEL cohort and its target population. Am J Epidemiol. 2001;154:373–84.
59. Vercambre MN, Gilbert F. Respondents in an epidemiologic survey had fewer psychotropic prescriptions than nonrespondents: an insight into health-related selection bias using routine health insurance data. J Clin Epidemiol. 2012;65:1181–9.
60. Institut de veille sanitaire. Estimation des taux de prévalence des anticorps anti-VHC et des marqueurs du virus de l’hépatite B chez les assurés sociaux du régime général de France métropolitaine, 2003–2004. Analyse descriptive. Saint Maurice: Institut de veille sanitaire; 2005.
61. Santin G, Geoffroy B, Bénézet L, Delézire P, Chatelot J, Sitta R, Bouyer J, Gueguen A. SNIIRAM Cohorts Group. In an occupational health surveillance study, auxiliary data from administrative health and occupational databases effectively corrected for nonresponse. J Clin Epidemiol. 2014;67(6):722–30.
62. Zins M, Berkman LF, Goldberg M, The CONSTANCES team. The CONSTANCES cohort, an epidemiological research infrastructure. Methods and results of the pilot phase. Epidemiol Biostat Public Health. 2013;10:e8921-1. doi:10.2427/8921.
63. http://www.bbmri-lpc.org/.